Autopsy report · NCT00876850

Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“Terminated”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 3
Sponsor: Paratek Pharmaceuticals Inc
Sponsor type: Industry
Conditions: Skin Structures and Soft Tissue Infections
Interventions: PTK 0796; Linezolid
Participants: 0

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.